skip to main content
Idioma:
Resultados 1 2 3 next page
Refinado por: Base de dados/Biblioteca: ClinicalKey remover Nome da Publicação: European Journal Of Cancer remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
2256 Chemoradiotherapy in esophageal cancer: The prognostic significance of smoking and/or drinking in the outcome of patients
2256 Chemoradiotherapy in esophageal cancer: The prognostic significance of smoking and/or drinking in the outcome of patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

2256 Chemoradiotherapy in esophageal cancer: The prognostic significance of smoking and/or drinking in the outcome of patients

Cardoso, C ; Esteves, S ; Luís, A ; Freire, J ; Pimenta, A ; Mão-Ferro, S ; Ferreira, S ; Serrano, M ; Bettencourt, A ; Moreira, A

European journal of cancer (1990), 2015-09, Vol.51, p.S418-S418 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Cancer rehabilitation indicators for Europe
Cancer rehabilitation indicators for Europe
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cancer rehabilitation indicators for Europe

Baili, Paolo ; Hoekstra-Weebers, Josette ; Van Hoof, Elke ; Bartsch, Hans Helge ; Travado, Luzia ; Garami, Miklos ; Di Salvo, Francesca ; Micheli, Andrea ; Veerus, Piret

European journal of cancer (1990), 2013-04, Vol.49 (6), p.1356-1364 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Colorectal cancer (CRC): program for early diagnosis in the disctrict Alba-Bra (ASl18), Piedmont - Italy
Colorectal cancer (CRC): program for early diagnosis in the disctrict Alba-Bra (ASl18), Piedmont - Italy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Colorectal cancer (CRC): program for early diagnosis in the disctrict Alba-Bra (ASl18), Piedmont - Italy

Destefanis, M. ; Dalla Mola, A. ; Castiglione, F. ; Ferro, S. ; Franchini, M. ; Galliano, M. ; Ostellino, O. ; Porcile, G.

European journal of cancer (1990), 2001-04, Vol.37, p.S238-S238 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Worldwide trends in gastric cancer mortality (1980–2011), with predictions to 2015, and incidence by subtype
Worldwide trends in gastric cancer mortality (1980–2011), with predictions to 2015, and incidence by subtype
Material Type:
Artigo 		Adicionar ao Meu Espaço

Worldwide trends in gastric cancer mortality (1980–2011), with predictions to 2015, and incidence by subtype

Ferro, Ana ; Peleteiro, Bárbara ; Malvezzi, Matteo ; Bosetti, Cristina ; Bertuccio, Paola ; Levi, Fabio ; Negri, Eva ; La Vecchia, Carlo ; Lunet, Nuno

European journal of cancer (1990), 2014-05, Vol.50 (7), p.1330-1344 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer: Results from Neo-ALTTO
The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer: Results from Neo-ALTTO
Material Type:
Artigo 		Adicionar ao Meu Espaço

The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer: Results from Neo-ALTTO

Di Cosimo, S. ; Campbell, C. ; Azim, H.A. ; Galli, G. ; Bregni, G. ; Curigliano, G. ; Criscitiello, C. ; Izquierdo, M. ; de la Pena, L. ; Fumagalli, D. ; Fein, L. ; Vinholes, J. ; Ng, W.M.J. ; Colleoni, M. ; Ferro, A. ; Naume, B.J. ; Patel, A. ; Huober, J. ; Piccart-Gebhart, M.J. ; Baselga, J. ; de Azambuja, E.

European journal of cancer (1990), 2018-01, Vol.89, p.42-48 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Adjuvant endocrine therapy choices in premenopausal patients with estrogen receptor-positive early breast cancer: insights from the GIM23-POSTER study
Adjuvant endocrine therapy choices in premenopausal patients with estrogen receptor-positive early breast cancer: insights from the GIM23-POSTER study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Adjuvant endocrine therapy choices in premenopausal patients with estrogen receptor-positive early breast cancer: insights from the GIM23-POSTER study

Arecco, L. ; Latocca, M.M. ; Blondeaux, E. ; Riccardi, F. ; Guarneri, V. ; Bisagni, G. ; Puglisi, F. ; Ferro, A. ; Adamo, V. ; Giovanardi, F. ; Tamberi, S. ; Donati, S. ; Landucci, E. ; Biganzoli, L. ; Rossi, V. ; Pastorino, S. ; de Azambuja, E. ; Poggio, F. ; Lambertini, M. ; Del Mastro, L.

European journal of cancer (1990), 2024-03, Vol.200, p.113698, Article 113698 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Everolimus plus aromatase inhibitors as maintenance therapy after first-line chemotherapy: Final results of the phase III randomised MAIN-A (MAINtenance Afinitor) trial
Everolimus plus aromatase inhibitors as maintenance therapy after first-line chemotherapy: Final results of the phase III randomised MAIN-A (MAINtenance Afinitor) trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Everolimus plus aromatase inhibitors as maintenance therapy after first-line chemotherapy: Final results of the phase III randomised MAIN-A (MAINtenance Afinitor) trial

Guarneri, Valentina ; Giorgi, Carlo Alberto ; Cinieri, Saverio ; Bengala, Carmelo ; Mariani, Gabriella ; Bisagni, Giancarlo ; Frassoldati, Antonio ; Zamagni, Claudio ; De Rossi, Costanza ; Amoroso, Vito ; Andreetta, Claudia ; Ferro, Antonella ; Zambelli, Alberto ; Gori, Stefania ; Garrone, Ornella ; Dieci, Maria Vittoria ; Orlando, Laura ; Pastina, Ilaria ; Beninato, Teresa ; Moretti, Gabriella ; Genovesi, Elisa ; Cinefra, Margherita ; Vicini, Roberto ; Magni, Giovanna ; De Salvo, Gian L. ; Conte, PierFranco

European journal of cancer (1990), 2021-09, Vol.154, p.21-29 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
The anion channel GPR89 is a novel oncogene associated with tumour specific dependency in breast cancer
The anion channel GPR89 is a novel oncogene associated with tumour specific dependency in breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

The anion channel GPR89 is a novel oncogene associated with tumour specific dependency in breast cancer

Ferro, R. ; Carroll, A. ; Mendes-Pereira, A. ; Reen, V. ; Roxanis, I. ; Annunziato, S. ; Jonkers, J. ; Liv, N. ; Alexander, J. ; Quist, J. ; Pardo, M. ; Roumeliotis, T.I. ; Choudhary, J.S. ; Weekes, D. ; Marra, P. ; Natrajan, R. ; Grigoriadis, A. ; Haider, S. ; Lord, C.J. ; Tutt, A.J.

European journal of cancer (1990), 2022-10, Vol.174, p.S50-S50 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Ten-year survival of neoadjuvant dual HER2 blockade in patients with HER2-positive breast cancer
Ten-year survival of neoadjuvant dual HER2 blockade in patients with HER2-positive breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ten-year survival of neoadjuvant dual HER2 blockade in patients with HER2-positive breast cancer

Nuciforo, Paolo ; Townend, John ; Piccart, Martine J. ; Fielding, Shona ; Gkolfi, Panagiota ; El-Abed, Sarra ; de Azambuja, Evandro ; Werutsky, Gustavo ; Bliss, Judith ; Moebus, Volker ; Colleoni, Marco ; Aspitia, Alvaro Moreno ; Gomez, Henry ; Gombos, Andrea ; Coccia-Portugal, Maria A. ; Tseng, Ling-Ming ; Kunz, Georg ; Lerzo, Guillermo ; Sohn, Joohyuk ; Semiglazov, Vladimir ; Saura, Cristina ; Kroep, Judith ; Ferro, Antonella ; Cameron, David ; Gelber, Richard ; Huober, Jens ; Di Cosimo, Serena

European journal of cancer (1990), 2023-03, Vol.181, p.92-101 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
Nine-year survival outcome of neoadjuvant lapatinib with trastuzumab for HER2-positive breast cancer (NeoALTTO, BIG 1-06): final analysis of a multicentre, open-label, phase 3 randomised clinical trial
Nine-year survival outcome of neoadjuvant lapatinib with trastuzumab for HER2-positive breast cancer (NeoALTTO, BIG 1-06): final analysis of a multicentre, open-label, phase 3 randomised clinical trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Nine-year survival outcome of neoadjuvant lapatinib with trastuzumab for HER2-positive breast cancer (NeoALTTO, BIG 1-06): final analysis of a multicentre, open-label, phase 3 randomised clinical trial

Nuciforo, P. ; Townend, J. ; Saura, C. ; de Azumbaja, E. ; Hilbers, F. ; Manukyants, A. ; Werutsky, G. ; Bliss, J. ; Moebus, V. ; Colleoni, M. ; Aspitia, A.Moreno ; Di Cosimo, S. ; Van dooren, V. ; Kroep, J. ; Ferro, A. ; Cameron, D. ; Gelber, R. ; Piccart-Gebhart, M. ; Huober, J.

European journal of cancer (1990), 2020-10, Vol.138, p.S15-S16 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 next page

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.